Current Cases

Kessler Topaz is currently representing and funding a group of over 500 institutional investors in securities litigation in Germany against […]

  This securities fraud class action involves claims against Mylan (n/k/a Viatris Inc.), the world’s second largest generic drug manufacturer,

This securities fraud class action case arises out of Goldman Sachs’ role in the 1Malaysia Development Berhad (“1MDB”) money laundering

Plaintiffs filed a Consolidated Class Action Complaint alleging that, having pursued and lost patent infringement litigation against would-be generic competitors

This securities fraud case involves Celgene’s misrepresentations and omissions about two billion dollar drugs, Otezla and Ozanimod, that Celgene touted

This securities fraud class action arises out of Boeing’s alleged misstatements and concealment of the significant safety issues with its